Breaking News Instant updates and real-time market news.

ADBE

Adobe

$156.60

0.83 (0.53%)

07:12
09/20/17
09/20
07:12
09/20/17
07:12

Adobe price target raised to $145 from $127.50 at Wells Fargo

Wells Fargo analyst Philip Winslow raised his price target for Adobe to $145 from $127.50 following Q3 results. The analyst reiterates a Market Perform rating on the shares.

  • 22

    Oct

ADBE Adobe
$156.60

0.83 (0.53%)

09/20/17
STFL
09/20/17
NO CHANGE
Target $163
STFL
Buy
Adobe near-term weakness would be buying opportunity, says Stifel
Stifel analyst Tom Roderick noted that most of Adobe's key metrics outperformed in Q3, but the company failed to achieve its bookings target in Experience Cloud as a result of elongating sales cycles. He recommends being a buyer on any near-term weakness after earnings, citing the company's leadership position in key markets and "unmatched profitability" compared to peers. Roderick keeps a $163 price target and Buy rating on Adobe shares.
09/20/17
JEFF
09/20/17
NO CHANGE
Target $180
JEFF
Buy
Jefferies ups Adobe target to $180, calls bookings miss 'speed bump'
The Q3 bookings miss in Experience Cloud detracted from Adobe's otherwise strong quarter, Jefferies analyst Brent Thill tells investors in a post-earnings research note titled "FQ3: One Cylinder Misfiring, But Still Running Faster Overall." The analyst sees the bookings miss as a "small speed bump" due to Adobe's growing enterprise deal sizes. He raised his price target on the shares to $180 from $175 and keeps a Buy rating on the name.
09/20/17
JPMS
09/20/17
NO CHANGE
Target $170
JPMS
Overweight
Adobe experience bookings to weigh on shares, says JPMorgan
Weaker than expected Adobe experience bookings in Q3 will weigh on shares, JPMorgan analyst Sterling Auty tells investors in a post-earnings research note titled "3Q17: Good, But Not as Great as 2Q17." The analyst is not concerned enough to change his thesis, however, saying the business is "working through growing pains and scale." He believes the stock selloff could provide a buying opportunity and keeps an Overweight rating on Adobe with a $170 price target.
09/20/17
PIPR
09/20/17
NO CHANGE
Target $180
PIPR
Overweight
Adobe earnings pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Alex Zukin views Adobe's Q3 results as solid and says the Experience Cloud bookings miss is due to longer sales cycles as it targets larger customers, not a change in demand or competitive dynamics. He continues to view Adobe as having some of the best intermediate and long-term fundamentals in the space. The analyst recommends using the "rare" pullback in the shares post-earnings as a buying opportunity. Zukin reiterates an Overweight rating on the name with a $180 price target.

TODAY'S FREE FLY STORIES

CLF

Cleveland-Cliffs

$7.02

-0.42 (-5.65%)

05:47
10/23/17
10/23
05:47
10/23/17
05:47
Downgrade
Cleveland-Cliffs rating change  »

Cleveland-Cliffs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$34.40

0.51 (1.50%)

05:44
10/23/17
10/23
05:44
10/23/17
05:44
Downgrade
Aerojet Rocketdyne rating change  »

Aerojet Rocketdyne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

05:30
10/23/17
10/23
05:30
10/23/17
05:30
General news
FX Action: USD-JPY has remained settled under 114.00 »

FX Action: USD-JPY has…

NVS

Novartis

$85.74

-0.42 (-0.49%)

05:29
10/23/17
10/23
05:29
10/23/17
05:29
Hot Stocks
Novartis receives FDA Breakthrough Therapy Designation for Tafinlar/Mekinist »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 08

    Nov

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 17

    May

BA

Boeing

$264.75

5.71 (2.20%)

05:25
10/23/17
10/23
05:25
10/23/17
05:25
Hot Stocks
Boeing, Mitsubishi Heavy reach agreement on cost reduction for 787 production »

Boeing and Mitsubishi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

BAC

Bank of America

$27.17

0.59 (2.22%)

05:24
10/23/17
10/23
05:24
10/23/17
05:24
Hot Stocks
Merrill Lynch fined $45.5M in Britain for not reporting derivative transactions »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ATHN

athenahealth

$126.04

9.63 (8.27%)

05:18
10/23/17
10/23
05:18
10/23/17
05:18
Upgrade
athenahealth rating change  »

athenahealth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATYY

Tate & Lyle

$33.23

-0.835 (-2.45%)

05:13
10/23/17
10/23
05:13
10/23/17
05:13
Upgrade
Tate & Lyle rating change  »

Tate & Lyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$48.37

0.24 (0.50%)

05:12
10/23/17
10/23
05:12
10/23/17
05:12
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELI

MercadoLibre

$235.73

-0.27 (-0.11%)

05:02
10/23/17
10/23
05:02
10/23/17
05:02
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$338.10

-4.32 (-1.26%)

04:59
10/23/17
10/23
04:59
10/23/17
04:59
Initiation
Biogen initiated  »

Biogen assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

CELG

Celgene

$121.33

-14.63 (-10.76%)

04:56
10/23/17
10/23
04:56
10/23/17
04:56
Downgrade
Celgene rating change  »

Celgene assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

ASOMY

ASOS

$74.28

1.5 (2.06%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

PAY

Verifone

$20.06

0.06 (0.30%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Verifone management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 14

    Dec

PLUG

Plug Power

$2.70

0.17 (6.72%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Plug Power to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 16

    Nov

DDAIF

Daimler AG

$80.57

-1.11 (-1.36%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

September Chicago Fed…

IVC

Invacare

$14.60

0.05 (0.34%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Invacare management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALXN

Alexion

$139.02

-1.44 (-1.03%)

04:54
10/23/17
10/23
04:54
10/23/17
04:54
Initiation
Alexion initiated  »

Alexion assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 06

    Nov

BIVV

Bioverativ

$60.22

0.49 (0.82%)

04:52
10/23/17
10/23
04:52
10/23/17
04:52
Initiation
Bioverativ initiated  »

Bioverativ assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 06

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

04:50
10/23/17
10/23
04:50
10/23/17
04:50
Downgrade
Tesaro rating change  »

Tesaro assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

04:48
10/23/17
10/23
04:48
10/23/17
04:48
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 02

    Feb

  • 14

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.